Atlas Trials

Fundacion SEIMC-GESIDA

30 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Fundacion SEIMC-GESIDA

RecordFirmDate
Effect of Extra Virgin Olive Oil Consumption on the Occurrence of Cardiovascular Events in Population Living With HIV (NCT07761819)Fundacion SEIMC-GESIDA2026-10-31
GRAM NEGATIVES STUDY (NCT07749508)Fundacion SEIMC-GESIDA2026-03-02
Study to Evaluate the Efficacy and Safety of a Rilpivarine-based Antiretroviral Tratment Regimen in HIV- Infected Patients With Liver Metabolic Disease Who Maintain Udetectable HIV Viral Load (NCT05898841)Fundacion SEIMC-GESIDA2023-05-26
Phase IV, a Clinical Trial to Assess Safety and Convenience of the Change From DTG/3TC to BIC/FTC/TAF in People With HIV, Good Virological Control and Neuropsychiatric Vulnerabilities (NCT05549180)Fundacion SEIMC-GESIDA2022-10-06
Simplified Model of Linkage and Retention to Care, Using a Mobile Unit and a Same-day Test and Treat Approach Among Excluded Population. (SIMPLIFIED) (NCT05405751)Fundacion SEIMC-GESIDA2022-07-04
Lamivudine/Dolutegravir in Virologically Suppressed Subjects With Expected or Confirmed Resistance to Lamivudine (NCT04880785)Fundacion SEIMC-GESIDA2021-07-28
DTG/3TC vs. BIC/FTC/TAF Maintenance Therapy in People Living With HIV: (NCT04884139)Fundacion SEIMC-GESIDA2021-07-14
A Phase IV Study to Assess the Impact of the Change of Antiretroviral Treatment From Dual Therapy to Triple Therapy on Inflammation in Patients With HIV Infection (NCT04076423)Fundacion SEIMC-GESIDA2019-10-10
Bezlotoxumab - in "Real Life" - During the First Episode of Clostridium Difficile Infection in Patients With High Risk of Recurrence. (NCT04075422)Fundacion SEIMC-GESIDA2019-10-01
A Clinical Trial to Evaluate the Reversibility of Abacavir/Lamivudine/Dolutegravir CNS-Related Neurotoxicity After Switching to Tenofovir/Alafenamide/Emtricitabine/Darunavir/Cobicistat (TAF/FTC/DRV/c) (NCT03685500)Fundacion SEIMC-GESIDA2018-12-04
A Clinical Trial to Evaluate the Immunogenicity of the Nonavalent Vaccine Against Human Papillomavirus in Men Infected by HIV Who Have Sex With Men. GESIDA 10017 (NCT03626467)Fundacion SEIMC-GESIDA2018-10-15
Spanish Cohort of Patients with HIV Infection Older Than 50 Years for the Study of Fragility and Physical Function (NCT03558438)Fundacion SEIMC-GESIDA2018-05-07
A Clinical Trial to Evaluate the Efficacy and Safety of Elvitegravir / Cobicistat / Emtricitabine / Tenofovir Alafenamide as a First-line Treatment in Naïve Patients With HIV-1 Infection With Severe Immunosuppression (NCT03693508)Fundacion SEIMC-GESIDA2018-04-13
A Phase IV, Open-label, Randomised, Pilot Clinical Trial Designed to Evaluate the Potential Neurotoxicity of Dolutegravir/Lamivudine/Abacavir in Neurosymptomatic HIV Patients and Its Reversibility After Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide. DREAM Study (NCT03067285)Fundacion SEIMC-GESIDA2017-09-08

Track Fundacion SEIMC-GESIDA automatically

Every clearance here is in the API, with alerts when new ones post.